Drug Shortage Report for DANTRIUM INTRAVENOUS
Report ID | 43728 |
Drug Identification Number | 01997572 |
Brand name | DANTRIUM INTRAVENOUS |
Common or Proper name | Dantrolene Sodium for Injection |
Company Name | ENDO OPERATIONS LTD. |
Market Status | MARKETED |
Active Ingredient(s) | DANTROLENE SODIUM |
Strength(s) | 20MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | Box containing 6x20mg Vial |
ATC code | M03CA |
ATC description | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-03-22 |
Estimated end date | 2018-07-15 |
Actual end date | 2018-07-30 |
Shortage status | Resolved |
Updated date | 2018-07-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-07-31 | English | Compare |
v9 | 2018-07-30 | French | Compare |
v8 | 2018-07-30 | English | Compare |
v7 | 2018-05-16 | French | Compare |
v6 | 2018-05-16 | English | Compare |
v5 | 2018-05-01 | French | Compare |
v4 | 2018-05-01 | English | Compare |
v3 | 2018-03-23 | English | Compare |
v2 | 2018-03-22 | French | Compare |
v1 | 2018-03-22 | English | Compare |
Showing 1 to 10 of 10